Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Colorectal Neoplasms × XELOX × Clear all

Phase

Status

Completed 11 Unknown 10 Recruiting 3 Not yet recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 3 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Adenocarcinoma of the Lower Rectum 1

Interventions

pembrolizumab 28 Bevacizumab 28 Oxaliplatin 25 Leucovorin 24 Fluorouracil 24 Irinotecan 21 Cetuximab 21 Capecitabine 16 Nivolumab 14 atezolizumab 10 Specimen Handling 10 Panitumumab 10 Paclitaxel 9 Carboplatin 9 trifluridine tipiracil drug combination 8 regorafenib 8 Trifluridine 7 Colonoscopy 7 Biopsy 7 Early Intervention, Educational 6 Cisplatin 6 Aspirin 6 tislelizumab 5 encorafenib 5 Standard of Care 5 Radiotherapy 5 Methods 5 Gemcitabine 5 Folfox protocol 5 Educational Status 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01531595 2024-12-12

AXOAXI

Helsinki University Central Hospital

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡